Drug recall · October 2, 2019
Lidocaine Hydroclhoride Jelly USP recall
Why: cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30
- Lots / codes
Lot #: 9B21A, Exp. 1/2022
- Quantity
- 10,543 tubes
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide within the United States and Puerto Rico
- Initiated
- September 17, 2019 · Voluntary: Firm initiated
- Classified
- September 24, 2019
- Reported
- October 2, 2019
- Ended
- August 1, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.